Amorepacific Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Amorepacific wird ein jährliches Gewinn- und Umsatzwachstum von 37.4% bzw. 14.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 38.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 8.6% betragen.

Wichtige Informationen

38.2%

Wachstumsrate der Gewinne

39.5%

EPS-Wachstumsrate

Personal Products Gewinnwachstum	34.1%
Wachstumsrate der Einnahmen	14.1%
Zukünftige Eigenkapitalrendite	8.6%
Analystenabdeckung	Good
Zuletzt aktualisiert	26 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Does Amorepacific's (KRX:090430) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 14

Amorepacific Corporation (KRX:090430) Shares Could Be 30% Above Their Intrinsic Value Estimate

Jan 31

The Trends At Amorepacific (KRX:090430) That You Should Know About

Jan 18

Amorepacific Corporation's (KRX:090430) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Jan 05

Is Amorepacific Corporation (KRX:090430) An Attractive Dividend Stock?

Dec 21

Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly

Dec 06

Could The Amorepacific Corporation (KRX:090430) Ownership Structure Tell Us Something Useful?

Nov 20

Gewinn- und Umsatzwachstumsprognosen

KOSE:A090430 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (KRW Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	5,433,682	522,170	583,467	687,577	18
12/31/2025	4,938,504	442,457	476,018	602,812	24
12/31/2024	4,269,270	321,482	350,345	429,844	24
3/31/2024	3,671,719	143,850	240,058	391,213	N/A
12/31/2023	3,673,964	152,522	174,760	348,228	N/A
9/30/2023	3,835,683	140,395	220,194	384,674	N/A
6/30/2023	3,883,262	136,604	283,188	453,528	N/A
3/31/2023	3,883,600	104,331	144,221	295,120	N/A
12/31/2022	4,134,933	134,475	16,101	151,024	N/A
9/30/2022	4,371,912	68,371	188,035	308,918	N/A
6/30/2022	4,544,441	84,039	240,729	357,734	N/A
3/31/2022	4,775,375	175,913	439,916	561,718	N/A
12/31/2021	4,863,128	193,681	570,824	691,434	N/A
9/30/2021	4,695,327	178,982	466,452	600,030	N/A
6/30/2021	4,675,027	148,728	498,866	651,475	N/A
3/31/2021	4,554,106	98,653	396,239	568,723	N/A
12/31/2020	4,432,179	35,132	339,700	554,359	N/A
9/30/2020	4,608,908	42,912	305,944	549,921	N/A
6/30/2020	4,922,270	137,275	363,995	625,898	N/A
3/31/2020	5,259,669	186,991	348,156	624,370	N/A
12/31/2019	5,580,142	238,804	439,375	718,301	N/A
9/30/2019	5,470,617	289,696	354,956	637,397	N/A
6/30/2019	5,347,037	234,594	124,318	483,115	N/A
3/31/2019	5,297,581	282,385	144,227	574,725	N/A
12/31/2018	5,277,845	332,195	191,031	646,677	N/A
9/30/2018	5,193,657	347,563	-27,746	604,822	N/A
6/30/2018	5,125,097	377,054	-134,015	618,357	N/A
3/31/2018	4,986,371	347,115	-290,595	444,561	N/A
12/31/2017	5,123,826	394,011	N/A	512,563	N/A
9/30/2017	5,299,895	450,531	N/A	537,348	N/A
6/30/2017	5,490,953	488,541	N/A	615,218	N/A
3/31/2017	5,729,430	600,383	N/A	678,329	N/A
12/31/2016	5,645,440	639,255	N/A	676,952	N/A
9/30/2016	5,555,181	636,268	N/A	696,200	N/A
6/30/2016	5,295,359	658,995	N/A	628,452	N/A
3/31/2016	5,047,329	628,616	N/A	690,384	N/A
12/31/2015	4,766,627	577,523	N/A	627,504	N/A
9/30/2015	4,519,611	550,538	N/A	636,223	N/A
6/30/2015	4,375,235	515,495	N/A	686,149	N/A
3/31/2015	4,146,542	466,286	N/A	682,951	N/A
12/31/2014	3,874,008	379,104	N/A	586,111	N/A
9/30/2014	3,600,095	373,665	N/A	558,426	N/A
6/30/2014	3,396,154	335,996	N/A	475,093	N/A
3/31/2014	3,228,442	298,132	N/A	445,513	N/A
12/31/2013	3,100,413	267,975	N/A	426,657	N/A
9/30/2013	3,043,461	257,412	N/A	370,498	N/A
6/30/2013	2,983,986	261,279	N/A	343,530	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: A090430Das prognostizierte Gewinnwachstum (36.8% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: A090430Die Erträge des Unternehmens (36.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt KR (28.3% pro Jahr).

Hohe Wachstumserträge: A090430Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: A090430Die Einnahmen des Unternehmens (14.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt KR (10.2% pro Jahr).

Hohe Wachstumseinnahmen: A090430Die Einnahmen des Unternehmens (14.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: A090430Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (8.6%).

Amorepacific Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates increase by 11%

Price target increased by 13% to ₩183,958

Consensus EPS estimates fall by 10%

Price target increased by 8.0% to ₩151,000

Consensus EPS estimates fall by 10%

Price target increased to ₩145,524

Recent updates

Is Amorepacific Corporation (KRX:090430) Potentially Undervalued?

A Look At The Intrinsic Value Of Amorepacific Corporation (KRX:090430)

Consensus EPS estimates increase by 11%

Investor sentiment improves as stock rises 19%

Price target increased by 13% to ₩183,958

Be Wary Of Amorepacific (KRX:090430) And Its Returns On Capital

Amorepacific Corporation (KRX:090430) Looks Just Right With A 26% Price Jump

Now 22% overvalued after recent price rise

Amorepacific (KRX:090430) Has A Pretty Healthy Balance Sheet

Amorepacific's (KRX:090430) Profits May Not Reveal Underlying Issues

Full year 2023 earnings released: EPS: ₩2,609 (vs ₩1,949 in FY 2022)

Amorepacific Corporation, Annual General Meeting, Mar 15, 2024

Amorepacific Corporation, Annual General Meeting, Mar 15, 2024

Amorepacific Unveils Research Demonstrating the Impact of Lymphatic Activating Ingredients

Now 22% overvalued after recent price rise

Upcoming dividend of ₩680 per share at 0.5% yield

New minor risk - Earnings quality

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 10%

Price target increased by 8.0% to ₩151,000

Amorepacific Corporation (KOSE:A090430) agreed to acquire additional 54.8% stake in Cosrxinc Co., Ltd. for approximately KRW 760 billion.

New major risk - Revenue and earnings growth

Consensus EPS estimates fall by 10%

Investor sentiment deteriorates as stock falls 15%

Full year 2022 earnings released: EPS: ₩1,949 (vs ₩2,820 in FY 2021)

Price target increased to ₩145,524

Upcoming dividend of ₩980 per share

Amorepacific and BTS Collaborate to Release Limited-Edition Set Featuring NEW "Butter" Lip Sleeping Mask Flavor

No independent directors

Consensus EPS estimates fall by 11%

Now 24% undervalued after recent price drop

Price target decreased to ₩132,833

Amorepacific Corporation (KOSE:A090430) entered into an agreement to acquire Tata's Natural Alchemy, LLC from Alliance Consumer Growth, LLC and M13 Ventures Management, LLC for WON 168.1 billion.

Price target decreased to ₩171,950

Amorepacific Corporation Develops First Chip-Less Wireless Electronic Skin Enabled by Semiconductors

Price target decreased to ₩180,150

Amorepacific Corporation Ordinary Shares to Be Deleted from OTC Equity

No independent directors

Investor sentiment improved over the past week

Upcoming dividend of ₩800 per share

Amorepacific Introduces Special Collaboration with BTS

Consensus EPS estimates fall to ₩7,087

Price target increased to ₩282,793

Price target increased to ₩268,464

Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly

Full year 2020 earnings released: EPS ₩512 (vs ₩3,477 in FY 2019)

Did You Miss Amorepacific's (KRX:090430) 41% Share Price Gain?

Does Amorepacific's (KRX:090430) Statutory Profit Adequately Reflect Its Underlying Profit?

Price target raised to ₩228,500

Amorepacific Corporation (KRX:090430) Shares Could Be 30% Above Their Intrinsic Value Estimate

Amorepacific Corporation to Report Fiscal Year 2020 Results on Feb 03, 2021

Analysts update estimates

Analysts update estimates

The Trends At Amorepacific (KRX:090430) That You Should Know About

New 90-day high: ₩220,500

Analysts update estimates

Amorepacific Corporation's (KRX:090430) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Is Amorepacific Corporation (KRX:090430) An Attractive Dividend Stock?

New 90-day high: ₩217,000

Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly

Could The Amorepacific Corporation (KRX:090430) Ownership Structure Tell Us Something Useful?

New 90-day high: ₩185,000

New 90-day low: ₩158,000

Analysts lower EPS estimates to ₩2,133

New 90-day high - ₩182,000

LB Investment Inc., Amorepacific Corporation (KOSE:A090430) and Smilegate Investment, Inc. acquired 23.7% stake in Baram International Co.,Ltd.

Amorepacific Corporation to Report First Half, 2020 Results on Jul 31, 2020

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum